Cargando…

Diuretic treatment before and after transcatheter aortic valve implantation: A Danish nationwide study

OBJECTIVES: We examined loop diuretic treatment before and 1-year after transcatheter aortic valve implantation (TAVI), as a proxy for changes in symptom severity and secondly assessed how changes in loop diuretics related to mortality risk. BACKGROUND: Randomized clinical trials suggest that approx...

Descripción completa

Detalles Bibliográficos
Autores principales: Begun, Xenia, Butt, Jawad Haider, Kristensen, Søren Lund, Weeke, Peter Ejvin, De Backer, Ole, Schou, Morten, Køber, Lars, Loldrup Fosbøl, Emil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019742/
https://www.ncbi.nlm.nih.gov/pubmed/36928217
http://dx.doi.org/10.1371/journal.pone.0282636
_version_ 1784908092439265280
author Begun, Xenia
Butt, Jawad Haider
Kristensen, Søren Lund
Weeke, Peter Ejvin
De Backer, Ole
Schou, Morten
Køber, Lars
Loldrup Fosbøl, Emil
author_facet Begun, Xenia
Butt, Jawad Haider
Kristensen, Søren Lund
Weeke, Peter Ejvin
De Backer, Ole
Schou, Morten
Køber, Lars
Loldrup Fosbøl, Emil
author_sort Begun, Xenia
collection PubMed
description OBJECTIVES: We examined loop diuretic treatment before and 1-year after transcatheter aortic valve implantation (TAVI), as a proxy for changes in symptom severity and secondly assessed how changes in loop diuretics related to mortality risk. BACKGROUND: Randomized clinical trials suggest that approximately one third of patients undergoing TAVI do not achieve symptom relief, but “all-comer” data are lacking. METHODS: Using Danish nationwide registries, we identified all citizens, who underwent TAVI from 2008 to 2019 and were alive at 1-year post-discharge. Loop diuretic treatment pre-TAVI and at 1-year post-TAVI were assessed and grouped as receiving 1) no-loop diuretics; 2) low: 1–40 mg of furosemide (or equivalent bumetanide) daily; 3) intermediate: 41–120 mg of furosemide daily; or 4) high: >120 mg furosemide daily. RESULTS: Among the 4431 patients undergoing TAVI, 2173 (49%) patients were not treated with loop diuretics at the time of TAVI, 918 (21%) had low-loop diuretics, 881 (20%) had intermediate-loop diuretics, and 459 (10%) had high-loop diuretics. At 1-year post-TAVI, 893 (20%) patients had increased, 1010 (23%) had reduced, and 2528 (57%) had unchanged loop diuretic treatment. The cumulative 5-year risk of death in patients surviving one year, was 61% (95% CI: 56.4% to 65.3%) in patients with increased and 47% (95% CI: 44.9% to 49.9%) in patients with reduced/unchanged loop diuretic treatment, respectively. In multivariable Cox proportional hazard analysis, increased loop diuretic treatment was associated with a higher risk of death compared with reduced/unchanged loop diuretic treatment (Hazard ratio: 1.4; 95% CI: 1.22 to 1.52). CONCLUSIONS: Among patients undergoing TAVI, surviving one year, one fifth of patients had increased loop diuretic treatment, and a little over one fifth had reduced loop diuretic treatment 1-year post-procedure. In patients with increased diuretic treatment, the risk of death was higher compared to those with reduced/unchanged loop diuretic treatment.
format Online
Article
Text
id pubmed-10019742
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-100197422023-03-17 Diuretic treatment before and after transcatheter aortic valve implantation: A Danish nationwide study Begun, Xenia Butt, Jawad Haider Kristensen, Søren Lund Weeke, Peter Ejvin De Backer, Ole Schou, Morten Køber, Lars Loldrup Fosbøl, Emil PLoS One Research Article OBJECTIVES: We examined loop diuretic treatment before and 1-year after transcatheter aortic valve implantation (TAVI), as a proxy for changes in symptom severity and secondly assessed how changes in loop diuretics related to mortality risk. BACKGROUND: Randomized clinical trials suggest that approximately one third of patients undergoing TAVI do not achieve symptom relief, but “all-comer” data are lacking. METHODS: Using Danish nationwide registries, we identified all citizens, who underwent TAVI from 2008 to 2019 and were alive at 1-year post-discharge. Loop diuretic treatment pre-TAVI and at 1-year post-TAVI were assessed and grouped as receiving 1) no-loop diuretics; 2) low: 1–40 mg of furosemide (or equivalent bumetanide) daily; 3) intermediate: 41–120 mg of furosemide daily; or 4) high: >120 mg furosemide daily. RESULTS: Among the 4431 patients undergoing TAVI, 2173 (49%) patients were not treated with loop diuretics at the time of TAVI, 918 (21%) had low-loop diuretics, 881 (20%) had intermediate-loop diuretics, and 459 (10%) had high-loop diuretics. At 1-year post-TAVI, 893 (20%) patients had increased, 1010 (23%) had reduced, and 2528 (57%) had unchanged loop diuretic treatment. The cumulative 5-year risk of death in patients surviving one year, was 61% (95% CI: 56.4% to 65.3%) in patients with increased and 47% (95% CI: 44.9% to 49.9%) in patients with reduced/unchanged loop diuretic treatment, respectively. In multivariable Cox proportional hazard analysis, increased loop diuretic treatment was associated with a higher risk of death compared with reduced/unchanged loop diuretic treatment (Hazard ratio: 1.4; 95% CI: 1.22 to 1.52). CONCLUSIONS: Among patients undergoing TAVI, surviving one year, one fifth of patients had increased loop diuretic treatment, and a little over one fifth had reduced loop diuretic treatment 1-year post-procedure. In patients with increased diuretic treatment, the risk of death was higher compared to those with reduced/unchanged loop diuretic treatment. Public Library of Science 2023-03-16 /pmc/articles/PMC10019742/ /pubmed/36928217 http://dx.doi.org/10.1371/journal.pone.0282636 Text en © 2023 Begun et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Begun, Xenia
Butt, Jawad Haider
Kristensen, Søren Lund
Weeke, Peter Ejvin
De Backer, Ole
Schou, Morten
Køber, Lars
Loldrup Fosbøl, Emil
Diuretic treatment before and after transcatheter aortic valve implantation: A Danish nationwide study
title Diuretic treatment before and after transcatheter aortic valve implantation: A Danish nationwide study
title_full Diuretic treatment before and after transcatheter aortic valve implantation: A Danish nationwide study
title_fullStr Diuretic treatment before and after transcatheter aortic valve implantation: A Danish nationwide study
title_full_unstemmed Diuretic treatment before and after transcatheter aortic valve implantation: A Danish nationwide study
title_short Diuretic treatment before and after transcatheter aortic valve implantation: A Danish nationwide study
title_sort diuretic treatment before and after transcatheter aortic valve implantation: a danish nationwide study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019742/
https://www.ncbi.nlm.nih.gov/pubmed/36928217
http://dx.doi.org/10.1371/journal.pone.0282636
work_keys_str_mv AT begunxenia diuretictreatmentbeforeandaftertranscatheteraorticvalveimplantationadanishnationwidestudy
AT buttjawadhaider diuretictreatmentbeforeandaftertranscatheteraorticvalveimplantationadanishnationwidestudy
AT kristensensørenlund diuretictreatmentbeforeandaftertranscatheteraorticvalveimplantationadanishnationwidestudy
AT weekepeterejvin diuretictreatmentbeforeandaftertranscatheteraorticvalveimplantationadanishnationwidestudy
AT debackerole diuretictreatmentbeforeandaftertranscatheteraorticvalveimplantationadanishnationwidestudy
AT schoumorten diuretictreatmentbeforeandaftertranscatheteraorticvalveimplantationadanishnationwidestudy
AT køberlars diuretictreatmentbeforeandaftertranscatheteraorticvalveimplantationadanishnationwidestudy
AT loldrupfosbølemil diuretictreatmentbeforeandaftertranscatheteraorticvalveimplantationadanishnationwidestudy